Stryker Stock Current Valuation
| SYK Stock | EUR 371.50 2.20 0.60% |
Valuation analysis of Stryker helps investors to measure Stryker's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Stryker's price fluctuation is out of control at this time. Calculation of the real value of Stryker is based on 3 months time horizon. Increasing Stryker's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Stryker stock is determined by what a typical buyer is willing to pay for full or partial control of Stryker. Since Stryker is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Stryker Stock. However, Stryker's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 371.5 | Real 0.0 | Hype 0.0 | Naive 365.5 |
The real value of Stryker Stock, also known as its intrinsic value, is the underlying worth of Stryker Company, which is reflected in its stock price. It is based on Stryker's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Stryker's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Stryker helps investors to forecast how Stryker stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Stryker more accurately as focusing exclusively on Stryker's fundamentals will not take into account other important factors: Stryker Company Current Valuation Analysis
Stryker's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Stryker Current Valuation | 101.82 B |
Most of Stryker's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stryker is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Stryker has a Current Valuation of 101.82 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Devices industry. The current valuation for all Germany stocks is significantly lower than that of the firm.
Stryker Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stryker's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Stryker could also be used in its relative valuation, which is a method of valuing Stryker by comparing valuation metrics of similar companies.Stryker is currently under evaluation in current valuation category among its peers.
Stryker Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0618 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 101.82 B | |||
| Shares Outstanding | 378.83 M | |||
| Shares Owned By Insiders | 1.79 % | |||
| Shares Owned By Institutions | 80.48 % | |||
| Price To Earning | 20.44 X | |||
| Price To Book | 5.77 X | |||
| Price To Sales | 4.90 X | |||
| Revenue | 18.45 B | |||
| Gross Profit | 11.65 B | |||
| EBITDA | 4.04 B | |||
| Net Income | 2.36 B | |||
| Cash And Equivalents | 1.84 B | |||
| Cash Per Share | 4.92 X | |||
| Total Debt | 11.86 B | |||
| Debt To Equity | 74.20 % | |||
| Current Ratio | 2.07 X | |||
| Book Value Per Share | 43.88 X | |||
| Cash Flow From Operations | 2.62 B | |||
| Earnings Per Share | 5.83 X | |||
| Price To Earnings To Growth | 2.82 X | |||
| Target Price | 287.72 | |||
| Number Of Employees | 51 K | |||
| Beta | 0.94 | |||
| Market Capitalization | 92.13 B | |||
| Total Asset | 36.88 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.10 % | |||
| Net Asset | 36.88 B | |||
| Last Dividend Paid | 2.84 |
About Stryker Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stryker's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stryker using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stryker based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Stryker Stock
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Stryker Stock please use our How to Invest in Stryker guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.